The 10X Fund, LP and its general partner, 10X Capital Management, LLC, were co-founded by Jim Czirr and Rod D. Martin as a biotech-focused hedge fund headquartered in Spokane, Washington. It is especially noted for its takeover and restructuring of Galectin Therapeutics, in which it is the largest institutional shareholder.